Overview of microRNA biology AM Mohr, JL Mott Seminars in liver disease 35 (01), 003-011, 2015 | 1116 | 2015 |
Sonic hedgehog paracrine signaling regulates metastasis and lymphangiogenesis in pancreatic cancer JM Bailey, AM Mohr, MA Hollingsworth Oncogene 28 (40), 3513-3525, 2009 | 359 | 2009 |
Rosiglitazone and Gemcitabine in combination reduces immune suppression and modulates T cell populations in pancreatic cancer SK Bunt, AM Mohr, JM Bailey, PM Grandgenett, MA Hollingsworth Cancer immunology, immunotherapy 62, 225-236, 2013 | 78 | 2013 |
Saturated free fatty acids induce cholangiocyte lipoapoptosis SK Natarajan, SA Ingham, AM Mohr, CJ Wehrkamp, A Ray, S Roy, ... Hepatology 60 (6), 1942-1956, 2014 | 61 | 2014 |
MicroRNA-200c modulates the expression of MUC4 and MUC16 by directly targeting their coding sequences in human pancreatic cancer P Radhakrishnan, AM Mohr, PM Grandgenett, MM Steele, SK Batra, ... PloS one 8 (10), e73356, 2013 | 57 | 2013 |
FoxO3 increases miR-34a to cause palmitate-induced cholangiocyte lipoapoptosis SK Natarajan, BA Stringham, AM Mohr, CJ Wehrkamp, S Lu, MA Phillippi, ... Journal of lipid research 58 (5), 866-875, 2017 | 46 | 2017 |
MUC1 regulates expression of multiple microRNAs involved in pancreatic tumor progression, including the miR-200c/141 cluster AM Mohr, JM Bailey, ME Lewallen, X Liu, P Radhakrishnan, F Yu, ... PloS one 8 (10), e73306, 2013 | 44 | 2013 |
Molecular pathology of early pancreatic cancer N Remmers, JM Bailey, AM Mohr, MA Hollingsworth Cancer Biomarkers 9 (1-6), 421-440, 2011 | 44 | 2011 |
Cholangiocarcinoma therapy with nanoparticles that combine downregulation of MicroRNA-210 with inhibition of cancer cell invasiveness Y Xie, Y Wang, J Li, Y Hang, L Jaramillo, CJ Wehrkamp, MA Phillippi, ... Theranostics 8 (16), 4305, 2018 | 42 | 2018 |
Targeting the NF-κB and mTOR pathways with a quinoxaline urea analog that inhibits IKKβ for pancreas cancer therapy P Radhakrishnan, VC Bryant, EC Blowers, RN Rajule, N Gautam, ... Clinical cancer research 19 (8), 2025-2035, 2013 | 40 | 2013 |
MUC1 regulates cyclin D1 gene expression through p120 catenin and β-catenin X Liu, TC Caffrey, MM Steele, A Mohr, PK Singh, P Radhakrishnan, ... Oncogenesis 3 (6), e107-e107, 2014 | 35 | 2014 |
Expression of core 3 synthase in human pancreatic cancer cells suppresses tumor growth and metastasis P Radhakrishnan, PM Grandgenett, AM Mohr, SK Bunt, F Yu, ... International journal of cancer 133 (12), 2824-2833, 2013 | 33 | 2013 |
Enhanced colorectal cancer metastases in the alcohol-injured liver AM Mohr, JJ Gould, JL Kubik, GA Talmon, CA Casey, P Thomas, DJ Tuma, ... Clinical & experimental metastasis 34, 171-184, 2017 | 32 | 2017 |
Infusion technique of hematopoietic progenitor cells and related adverse events (CME) SB Mulay, CW Greiner, A Mohr, SC Bryant, RK Lingineni, D Padley, ... Transfusion 54 (8), 1997-2003, 2014 | 28 | 2014 |
MicroRNA function in human diseases SK Natarajan, MA Smith, CJ Wehrkamp, AM Mohr, JL Mott Medical Epigenetics 1 (1), 106-115, 2013 | 24 | 2013 |
miR-106b-responsive gene landscape identifies regulation of Kruppel-like factor family CJ Wehrkamp, SK Natarajan, AM Mohr, MA Phillippi, JL Mott RNA biology 15 (3), 391-403, 2018 | 9 | 2018 |
Glycosylation of FGFR4 in cholangiocarcinoma regulates receptor processing and cancer signaling AJ Phillips, MB Lobl, YA Hafeji, HR Safranek, AM Mohr, JL Mott Journal of cellular biochemistry 123 (3), 568-580, 2022 | 6 | 2022 |
MUC1 modulation of E-cadherin through miR-200c and ZEB1 AM Mohr, ME Lewallen, P Radhakrishnan, X Liu, JM Bailey, ... Cancer Research 72 (8_Supplement), 2308-2308, 2012 | 2 | 2012 |
Alcohol Consumption is associated with Increased CEA Levels in Male Patients with Stage IV Colorectal Cancer-A Single-Institution Retrospective Analysis LM Keim, AW Praus, WS Campbell, KK Samson, AM Mohr, M Tobi, ... Graduate Medical Education Research Journal 3 (1), 1, 2021 | 1 | 2021 |
Rosiglitazone and Gemcitabine combination therapy reduces immune suppression and modulates T cell populations in pancreatic cancer SK Bunt, AM Mohr, JM Bailey, PM Grandgenett, MA Hollingsworth Cancer Research 72 (8_Supplement), 1554-1554, 2012 | 1 | 2012 |